Hongchang International Co Ltd is a holding company mainly engaged in research and development and manufacture a medical product. Hongchang International Co Ltd, formerly known as Heyu Biological Technology Corp, is based in China.
| Revenue (Most Recent Fiscal Year) | $2.87M |
| Net Income (Most Recent Fiscal Year) | $-0.47M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 7.29 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.54 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -17.26% |
| Net Margin (Trailing 12 Months) | -16.50% |
| Return on Equity (Trailing 12 Months) | -1.19% |
| Return on Assets (Trailing 12 Months) | -0.83% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.21 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.21 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.17 |
| Inventory Turnover (Trailing 12 Months) | 2.95 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.38 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $0.00 |
| Exchange | -- |
| Sector | -- |
| Industry | -- |
| Common Shares Outstanding | 103.25M |
| Free Float | 11.11M |
| Market Capitalization | $20.91M |
| Average Volume (Last 20 Days) | 26.30 |
| Beta (Past 60 Months) | -28.06 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 89.24% |
| Percentage Held By Institutions (Latest 13F Reports) | 0.00% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |